France’s Enterome Eyes Merger To Make NASDAQ Move
As IBD Pact Is Signed With Nestlé
CEO Pierre Belichard tells Scrip that the French biotech has enough cash and assets to prosper alone but it is also weighing up a reverse merger that would give Enterome a listing on the NASDAQ.
